Following evidence of tumor shrinkage in a recent clinical trial by New Jersey cancer researchers, new study has begun to further measure the effects of a drug commonly used for Lou Gehrig's disease (ALS) in the treatment of melanoma. At focus is the drug riluzole.
"Taking out the trash" takes on a whole new meaning, as New Jersey researchers have discovered that a waste disposal protein is the key to cancer tumor suppression in a process known as autophagy. The latest research, which appears in this week's print and online editions of Cell, focuses on a protein known as p62.
New research shows that most parents who undergo genetic testing to assess their risk of breast cancer in particular, tell their young children of the results. The study, presented at the annual American Society of Clinical Oncology meeting, also looks at how parents perceive their child's reaction to such news.
More than one million people across the United States are currently affected by skin cancer. As the unofficial arrival of summer fast approaches, New Jersey's only NCI-designated Comprehensive Cancer Center is making experts available to discuss the risks for skin cancer and prevention tips.
A unique milestone has been reached in prostate cancer surgery at New Jersey's only NCI-designated Comprehensive Cancer Center. Dr. Isaac Kim has performed his 500th robotic prostatectomy, utilizing an enhanced procedure he developed, which is becoming a fast-growing standard of care in the removal of prostate cancer.
Researchers at New Jersey's only NCI-designated Comprehensive Cancer Center have launched a clinical trial targeting a new treatment for the most common type of non-invasive breast cancer. The study will note the effects of adding the drug trastuzumab to radiation therapy for patients who have undergone a lumpectomy.
Researchers at New Jersey's only NCI-designated Comprehensive Cancer Center are looking at an advanced radiation treatment for pancreatic cancer. At focus is Intensity Modulated Radiation Therapy (IMRT), which is considered a more sophisticated delivery technique that can preserve healthy tissue.
Since Florence Nightingale worked to improve the medical conditions of soldiers, nursing has progressed into a profession of caregivers with both clinical knowledge and technical expertise. Continually building on this proud tradition, nurses at New Jersey's only NCI-designated Comprehensive Cancer Center highlight their research before their peers.
Researchers from New Jersey's only NCI-designated Comprehensive Cancer Center are presenting findings on a combined treatment targeting breast cancer that is stimulated by the hormone estrogen. At focus is how the FDA-approved therapy fulvestrant can influence the effects of chemotherapy drugs on breast cancer cells.
New Jersey researchers are presenting findings on the interaction between a tumor cell and its environment, and how manipulation of those surroundings can lead to new targeted cancer therapies. At focus are mesenchymal stromal cells, which make up the outer connective tissue of a cancer tumor.
Thanks to the Lance Armstrong Foundation, New Jersey's only Comprehensive Cancer Center will expand a clinical program that meets the unique needs of cancer survivors. The $100,000 grant will fund an education program for healthcare workers, who are on the front lines in helping survivors meet various challenges.
New Jersey's only NCI-designated Comprehensive Cancer Center is celebrating the contributions of its Resource and Learning Center during National Library Week (April 12 "“ 18). This center provides unique books and audio/visual aids to both patients and the public to further educate them about the disease.
New Jersey's only NCI-designated Comprehensive Cancer Center is highlighting its clinical trial program during this National Cancer Control Awareness Month. One of the components experts focus on is the importance of having access to trial information right at one's fingertips.
During this National Cancer Control Month, New Jersey's only NCI-designated Comprehensive Cancer Center is focusing on unique research efforts taking place at its facility. Biomedical informatics, work with zebrafish and study of circadian rhythms and survivorship issues are among the highlights experts can discuss.
A new study shows better survival outcomes for women who have ovarian and endometrial cancers at the same time than those who only have one tumor in the ovaries. The research from New Jersey's only Comprehensive Cancer Center is published in the April edition of Obstetrics and Gynecology.
Researchers are looking at the drugs Celebrex and Lipitor, used respectively for arthritis pain and lowering one's cholesterol, to see if they can slow or stop the growth of prostate cancer when combined. The new study has just opened at New Jersey's only NCI-designated Comprehensive Cancer Center.
New research published in the Journal of Clinical Oncology shows a treatment combination used in breast and lung cancers to be effective against Hodgkin's disease in pre-teens and young adults, which make up to 10 to 15 of all U.S. cases. At focus are the drugs Gemcitabine and Vinorelbine.
Statistics show 90 percent of smokers start before age 21. That is why youth nationwide will raise awareness about tobacco use on March 25th during the 14th annual Kick Butts Day. Experts at New Jersey's only NCI-designated Comprehensive Cancer Center are available for comment on the development of lung cancer and other related effects of smoking.
A clinical trial to evaluate a new treatment for metastatic breast cancer in combination with one that is already approved for liver and kidney cancers is underway at New Jersey's only NCI-designated Comprehensive Cancer Center. Researchers will test the effectiveness of sorafenib when paired with letrozole.
Colorectal cancer is the third most common type of cancer in men and women and is the third leading cause of cancer death in the nation. Nearly 149,000 new cases of the disease were diagnosed nationwide last year. Experts from New Jersey's only NCI-designated Comprehensive Cancer Center are available for comment.
Social workers are society's safety net, providing vital resources and support when they are most needed, particularly, the psychosocial needs of oncology patients. Experts from New Jersey's only NCI-designated Comprehensive Cancer Center are available for comment on the unique support social workers provide for those with cancer.
Nearly 70,000 cases of bladder cancer were diagnosed nationwide last year. That's why researchers are looking at an FDA-approved treatment for kidney cancer when combined with the standard of care for bladder cancer. At focus is one of the newer "targeted therapies" known as sorafenib.
New Jersey's only NCI-designated Comprehensive Cancer Center is taking part in a worldwide clinical trial targeting HER2 positive breast cancer, which accounts for up to 25 percent of all breast cancers. Investigators will look at multiple combinations of the drugs Lapatinib and Trastuzumab.
As advanced technology continues to allow for the simplification and collection of health care and research data, experts want to streamline that process. Two New Jersey institutions brought together intellectual leaders to address challenges in the gathering and analysis of health care information for the benefit of patients.
New Jersey's only NCI-designated Comprehensive Cancer Center soon will have access to unique imaging technology right at its fingertips, thanks to a generous gift from the J. Seward Johnson, Sr. 1963 Charitable Trust. The new machinery will provide researchers with enhanced visualization of cancer cells.
A new robotic surgical technique developed for the removal of all or part of the prostate gland is showing what investigators call a "dramatic improvement" in a male's sexual potency rate. The results were recently presented at the 26th World Congress Endourology meeting in Shanghai, China.
February is Screening and Early Detection for Cancer Month. Abnormal cells that can become cancer cells can be detected through a variety of tests, many of which are recommended on a regular basis based on age, general health and overall risk factors.
Does shift work predispose one to breast or prostate cancer by altering the body's response to hormones? And if so, can a dietary supplement help? Those are the questions researchers hope to answer through a new study which looks at the effects of this supplement on one's circadian rhythm.
If you were being told that you were at genetic risk of developing breast cancer, would you want to find out over the phone? New research finds convenience plays a large role in the answer to that question.
By the year 2050 there will be more cancer survivors in the United States than those newly diagnosed with the disease. That is why researchers are taking a closer look at the specific needs of cancer survivors as they transition from specialty care back to their primary care provider.
Scientists at two New Jersey institutions have identified a long-sought gene responsible for metastasis in 30 to 40 percent of all breast cancer patients. The research, published in the January 6 edition of Cancer Cell, also describes how this gene is resistant to traditional chemotherapy treatments.
A New Jersey researcher has received an American Cancer Society Grant to investigate melanoma development with the hope of interrupting cell division or eliminating those cells. Through the study of a certain protein, the team hopes the information will also lead to the identification of a new prognostic marker for the disease.
Nearly 4,000 women nationwide will die of cervical cancer by the end of this year. The spotlight shines on this topic for the month of January. Experts are available to discuss overall cervical health awareness including cancer risk factors and prevention options.
An NCI-sponsored clinical trial looks at an experimental DNA repair drug in combination with a chemotherapy agent for treatment of solid cancer tumors and non-Hodgkin's lymphoma.
Giving teens with cancer a place of their own while undergoing treatment, the Alicia Rose Victorious Foundation once again helps provide comfort with a generous gift to refurbish the "teen lounge" at one of the nation's Comprehensive Cancer Centers.
Fatigue is a distressing side effect of cancer and can affect one's sense of well-being and even compliance with treatment. During this Cancer-Related Fatigue Awareness Month, experts are available to discuss this condition, which can become more prevalent during the busy holiday season.
The caring and curing efforts of over 125,000 nurse practitioners will be recognized during National Nurse Practitioner Week, which begins November 9. Some 600 million visits are made annually to NP's, who provide direct clinical care to patients as well as engage in health education and research.
Pancreatic cancer is the fourth leading cancer killer in the country. Experts are available to discuss risks, treatment and prevention options during this National Pancreatic Cancer Awareness Month, including immune therapy and the benefits of comprehensive care.
Some 161,000 lung cancer deaths are expected in the U.S. in 2008, which accounts for nearly a third of all cancer deaths. Experts can discuss risks, treatment and prevention options during this Lung Cancer Awareness Month, including the topics of palliative care and genetic marker study.
One can start the day with a "˜cup of joe' and a good deed through the purchase of a Pink Ribbon Bagel from Panera Bread. A portion of the proceeds from the specialty item will support breast cancer programs at New Jersey's only National Cancer Institute Designated-Comprehensive Cancer Center.
Researchers are investigating a new combination of chemotherapy drugs targeted at patients who have been diagnosed with previously untreated triple-negative metastatic breast cancer.
Researchers are investigating whether partial breast radiation following a lumpectomy will hold a better benefit than radiation of the whole breast. Under Accelerated Partial Breast Irradiation, patients will receive radiation to only a portion of their breast over a three-week period versus the traditional six or seven.
Research in the areas of triple-negative breast cancer, breast brachytherapy, partial breast radiation and education on the benefits of breast self-exams and programs for young women with breast cancer are at focus during October, which is National Breast Cancer Awareness Month.
With the Stand Up To Cancer telethon having raised millions of dollars, now the real work begins on applying that money toward the next generation of cancer research. Experts can discuss the latest in cutting-edge research in the areas of bioinformatics, work with zebrafish and survivorship issues.
While rare, 10,700 cases of childhood cancer will be diagnosed this year. Great strides in comprehensive care for such patients have been made, helping to keep the five-year survival rate for this group at 80 percent and trending upward. Experts can discuss unique programs that benefit this population.
The Stand Up To Cancer campaign is opening the nation's eyes to the need and the benefit of cancer research dollars. Top cancer experts are embarking on groundbreaking research, which include a look at active surveillance therapy in prostate cancer and investigation of the mineral selenium in ovarian cancer.
Upcoming Stand Up To Cancer campaign being used as springboard for discussion to remind and further educate cancer patients about a comprehensive website listing of all cancer clinical trials in New Jersey. Experts available to discuss need and benefit of such a resource.
New research to be published in JAMA shows a lack of survival benefit for older men with localized prostate cancer when administered a common hormone therapy. Authors say the treatment did not show any increase in the overall survival rate compared to conservative management.
With July being "Health-Promoting Lifestyles for Cancer Prevention Month," cancer experts are available to discuss the role of healthy eating for the summer barbecue season.
New research findings indicate the potential for more targeted treatment of ovarian cancer through the use of the mineral selenium in combination with the standard treatment for the disease.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right